摘要
目的:探讨恶性肿瘤特异性生长因子(TSGF)与糖类抗原125(CA125)联合检测对卵巢恶性肿瘤的诊断价值。方法:分别应用比色法和酶联免疫吸附法测定初诊卵巢恶性肿瘤患者(n=65)血清TSGF和CA125,并与卵巢良性肿瘤组(n=32)和健康对照组(n=24)对照。结果:卵巢恶性肿瘤组血清TSGF和CA125水平和阳性率均明显高于卵巢良性肿瘤组和健康对照组(P<0.01),二者联合检测阳性率为93.8%,高于各单项检测。结论:血清TSGF和CA125联合检测卵巢恶性肿瘤可提高诊断阳性率,对卵巢恶性肿瘤临床诊断有一定应用价值。
Objective：To evaluate the value of serum TSGF detection combined with CA125 in diagnosis of ovarian malignant tumors. Methods： Serum TSGF and CA125 were determined with ehromatometry and enzyme -linked immuno - sorbent assay in 65 cases of primary ovarian malignant tumors,32 patients of ovarian benign tumors and 24 normal subjects. Results： The levels and positive rate of serum TSGF and CA125 in ovarian malignant tumor group were higher than that in ovarian benign tumors and normal subjects （ P 〈 0. 01 ） . The positive rate of serum TSGF combined with CA125 was higher than that in each test alone. Conclusion ： There was significant value of serum TS- GF test combined with CA125 in diagnosis of ovarian malignant tumors.
出处
《现代肿瘤医学》
CAS
2009年第5期925-926,共2页
Journal of Modern Oncology
